AUSTIN, Texas, July 18, 2014 /PRNewswire-iReach/ -- Radyalis, a leader in advanced particle therapy software, will be showcasing its high performance Monte Carlo dose calculation product for proton applications simultaneously with the 2014 American Association of Physics in Medicine (AAPM) annual meeting in Austin, TX.
Radyalis breakthroughs in large-scale optimization and high-performance computing, enables for the first time clinicians to utilize the high accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Radyalis Monte Carlo engine fundamentally changes today's radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.
Radyalis technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware including single and multiple node installations, clusters, and cloud platforms, for both Linux and Windows environments. Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.
Without compromise, Radyalis Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials, and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence, and linear energy transfer, further guiding the radiation physicist.
The Radyalis fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance, and ultimately real-time adaptive planning. The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers, and research organizations.
Radyalis develops and markets high performance software for radiotherapy applications that enable next-generation treatment planning and patient workflow. Based in Austin, Texas, the Radyalis team collectively brings 60+ years of related research and development experience to the particle therapy arena with focus on ultra-fast and accurate scanning-beam proton applications with extensions to other particle therapy methods. Radyalis has deep collaborations with premier oncology research hospitals and is committed to fundamentally impacting the accuracy, productivity, and cost of treatment planning through the increased use of automation.
Media Contact: David LaPotin, Radyalis, 512-333-1619, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Copyright©2014 PR Newswire.
All rights reserved